3-(3-Amino-4-chlorophenyl)prop-2-enoic acid | 1262014-52-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 3-(3-Amino-4-chlorophenyl)prop-2-enoic acid
• CAS: 1262014-52-7
• 化学式: C₉H₈ClNO₂
• mdl: MFCD18389489
• 分子量: 197.621
• InChiKey: HUZALGAHTHHAQG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.02
• 重原子数：
  13.0
• 可旋转键数：
  2.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  63.32
• 氢给体数：
  2.0
• 氢受体数：
  2.0

反应信息

• 作为反应物：
  描述：

  3-(3-Amino-4-chlorophenyl)prop-2-enoic acid 、 乙酸酐 在 溶剂黄146 作用下， 生成 3-Acetamido-4-chlorocinnamic acid
  参考文献：
  名称：

  Substituted 2H-isoquinolin-1-one as potent Rho-Kinase inhibitors. Part 1: Hit-to-lead account

  摘要：

  Two closely related scaffolds were identified through an uHTS campaign as desirable starting points for the development of Rho-Kinase (ROCK) inhibitors. Here, we describe our hit-to-lead evaluation process which culminated in the rapid discovery of potent leads such as 22 which successfully demonstrated an early in vivo proof of concept for anti-hypertensive activity. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.04.070
• 作为产物：
  描述：

  4-chloro-3-nitro-cinnamic acid 在 盐酸 、 tin(ll) chloride 作用下， 以 水 为溶剂， 生成 3-(3-Amino-4-chlorophenyl)prop-2-enoic acid
  参考文献：
  名称：

  Substituted 2H-isoquinolin-1-one as potent Rho-Kinase inhibitors. Part 1: Hit-to-lead account

  摘要：

  Two closely related scaffolds were identified through an uHTS campaign as desirable starting points for the development of Rho-Kinase (ROCK) inhibitors. Here, we describe our hit-to-lead evaluation process which culminated in the rapid discovery of potent leads such as 22 which successfully demonstrated an early in vivo proof of concept for anti-hypertensive activity. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.04.070

文献信息

• [EN] NOVEL EP2 RECEPTOR AGONISTS<br/>[FR] NOUVEAUX AGONISTES DU RÉCEPTEUR EP2
  申请人：TAKEDA GMBH

  公开号：WO2013164326A1

  公开（公告）日：2013-11-07

  The compounds of formula (1), in which R1, R4, A and X have the meanings as given in the description, are novel effective EP2 agonists.

  式（1）中的化合物，其中R1、R4、A和X的含义如描述中所述，是新颖有效的EP2激动剂。
• NOVEL EP2 RECEPTOR AGONISTS
  申请人：Takeda GmbH

  公开号：EP2844638A1

  公开（公告）日：2015-03-11